InvestLog
HIND Vyome Holdings, Inc. logo

HIND Vyome Holdings, Inc.

Healthcare
$2.29+0.00%OpenMarket Cap: $12.9M

As of 2026-05-26

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

1.96

P/S

9.34

EV/EBITDA

-0.70

DCF Value

$1.84

FCF Yield

-24.4%

Div Yield

0.0%

Margins & Returns

Gross Margin

48.2%

Operating Margin

-401.9%

Net Margin

-985.5%

ROE

-302.1%

ROA

-130.1%

ROIC

-67.0%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$31.6K$-962.9K$—
Q4 null$36.6K$-1.2M$—
FY null$319.7K$-10.3M$—
Q3 null$34.6K$-8.4M$—

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$15.00

Target (Median)

$15.00

Target Range

$15.00 - $15.00

1 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell

Trading Activity

Insider Trades

View All
Pomichter Stanley D IIIdirector
SellWed Nov 19
Pomichter Stanley D IIIdirector:
SellWed Nov 19
Jolly Mohanjitdirector
SellTue Nov 18
Jolly Mohanjitdirector:
SellTue Nov 18
Tincoff John M. IIIdirector
SellMon Nov 17

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

US

Exchange

—

Beta

1.39

Vyome Holdings Inc., a clinical-stage healthcare company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States and global markets. The company was founded in 2017 and is based in Princeton, New Jersey.

Peers

ARMP logoARMPCCCC logoCCCCCDXS logoCDXSCGEN logoCGENIMDX logoIMDXIPHA logoIPHANVCT logoNVCTOABI logoOABISGMO logoSGMOTNXP logoTNXP